APO Research
Talk to an analyst

APO RESEARCH · REPORT

EPA & DHA Omega-3

Compare research editions
View pricing & licenses

Selected research

Industry Research

EPA & DHA Omega-3 Industry Research Report 2026

19 December 2025142 pages

Choose your research edition.

Industry ResearchEPA & DHA Omega-3 Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal EPA & DHA Omega-3 Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal EPA & DHA Omega-3 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal EPA & DHA Omega-3 Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal EPA & DHA Omega-3 Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global EPA & DHA Omega-3 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for EPA & DHA Omega-3 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for EPA & DHA Omega-3 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for EPA & DHA Omega-3 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of EPA & DHA Omega-3 include Shandong Yuwang Pharmaceutical, Xinzhou, TASA, Solutex, Skuny, Sinomega, Polaris, Orkla Health and Omega Protein, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global EPA & DHA Omega-3 market in terms of revenue (US$ million) and, where applicable, sales volume (K Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

EPA & DHA Omega-3 Market by Company

Shandong Yuwang Pharmaceutical

Xinzhou

TASA

Solutex

Skuny

Sinomega

Polaris

Orkla Health

Omega Protein

OLVEA Fish Oils

Nippon Suisan Kaisha

Maruha Nichiro Foods

Marine Ingredients

LYSI

Kinomega

KD Pharma

Hofseth BioCare

Golden Omega

GC Rieber

EPAX

DSM

Croda

Bioprocess Algae

BASF

Auqi

Anti-Cancer

EPA & DHA Omega-3 Segment by Type

Marine Animals Source Omega-3

Marine Plant Source Omega-3

EPA & DHA Omega-3 Segment by Application

Pet Foods

Fortified Food and Beverage

Dietary Supplements

Pharmaceuticals

Infant Formula

Others

EPA & DHA Omega-3 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EPA & DHA Omega-3 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of EPA & DHA Omega-3 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EPA & DHA Omega-3.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of EPA & DHA Omega-3 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of EPA & DHA Omega-3 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of EPA & DHA Omega-3 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global EPA & DHA Omega-3 Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global EPA & DHA Omega-3 Sales (K Tons) of Manufacturers (2021-2026) Table 7. Global EPA & DHA Omega-3 Sales Market Share by Manufacturers (2021-2026) Table 8. Global EPA & DHA Omega-3 Revenue of Manufacturers (2021-2026) Table 9. Global EPA & DHA Omega-3 Revenue Share by Manufacturers (2021-2026) Table 10. Global Market EPA & DHA Omega-3 Average Price (US$/Ton) of Manufacturers (2021-2026) Table 11. Global EPA & DHA Omega-3 Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of EPA & DHA Omega-3, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of EPA & DHA Omega-3, Product Type & Application Table 14. Global EPA & DHA Omega-3 Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global EPA & DHA Omega-3 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Shandong Yuwang Pharmaceutical Company Information Table 19. Shandong Yuwang Pharmaceutical Business Overview Table 20. Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 21. Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Product Portfolio Table 22. Shandong Yuwang Pharmaceutical Recent Developments Table 23. Xinzhou Company Information Table 24. Xinzhou Business Overview Table 25. Xinzhou EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 26. Xinzhou EPA & DHA Omega-3 Product Portfolio Table 27. Xinzhou Recent Developments Table 28. TASA Company Information Table 29. TASA Business Overview Table 30. TASA EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 31. TASA EPA & DHA Omega-3 Product Portfolio Table 32. TASA Recent Developments Table 33. Solutex Company Information Table 34. Solutex Business Overview Table 35. Solutex EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 36. Solutex EPA & DHA Omega-3 Product Portfolio Table 37. Solutex Recent Developments Table 38. Skuny Company Information Table 39. Skuny Business Overview Table 40. Skuny EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 41. Skuny EPA & DHA Omega-3 Product Portfolio Table 42. Skuny Recent Developments Table 43. Sinomega Company Information Table 44. Sinomega Business Overview Table 45. Sinomega EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Sinomega EPA & DHA Omega-3 Product Portfolio Table 47. Sinomega Recent Developments Table 48. Polaris Company Information Table 49. Polaris Business Overview Table 50. Polaris EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 51. Polaris EPA & DHA Omega-3 Product Portfolio Table 52. Polaris Recent Developments Table 53. Orkla Health Company Information Table 54. Orkla Health Business Overview Table 55. Orkla Health EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 56. Orkla Health EPA & DHA Omega-3 Product Portfolio Table 57. Orkla Health Recent Developments Table 58. Omega Protein Company Information Table 59. Omega Protein Business Overview Table 60. Omega Protein EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. Omega Protein EPA & DHA Omega-3 Product Portfolio Table 62. Omega Protein Recent Developments Table 63. OLVEA Fish Oils Company Information Table 64. OLVEA Fish Oils Business Overview Table 65. OLVEA Fish Oils EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. OLVEA Fish Oils EPA & DHA Omega-3 Product Portfolio Table 67. OLVEA Fish Oils Recent Developments Table 68. Nippon Suisan Kaisha Company Information Table 69. Nippon Suisan Kaisha Business Overview Table 70. Nippon Suisan Kaisha EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Nippon Suisan Kaisha EPA & DHA Omega-3 Product Portfolio Table 72. Nippon Suisan Kaisha Recent Developments Table 73. Maruha Nichiro Foods Company Information Table 74. Maruha Nichiro Foods Business Overview Table 75. Maruha Nichiro Foods EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Maruha Nichiro Foods EPA & DHA Omega-3 Product Portfolio Table 77. Maruha Nichiro Foods Recent Developments Table 78. Marine Ingredients Company Information Table 79. Marine Ingredients Business Overview Table 80. Marine Ingredients EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. Marine Ingredients EPA & DHA Omega-3 Product Portfolio Table 82. Marine Ingredients Recent Developments Table 83. LYSI Company Information Table 84. LYSI Business Overview Table 85. LYSI EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. LYSI EPA & DHA Omega-3 Product Portfolio Table 87. LYSI Recent Developments Table 88. Kinomega Company Information Table 89. Kinomega Business Overview Table 90. Kinomega EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Kinomega EPA & DHA Omega-3 Product Portfolio Table 92. Kinomega Recent Developments Table 93. KD Pharma Company Information Table 94. KD Pharma Business Overview Table 95. KD Pharma EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. KD Pharma EPA & DHA Omega-3 Product Portfolio Table 97. KD Pharma Recent Developments Table 98. Hofseth BioCare Company Information Table 99. Hofseth BioCare Business Overview Table 100. Hofseth BioCare EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Hofseth BioCare EPA & DHA Omega-3 Product Portfolio Table 102. Hofseth BioCare Recent Developments Table 103. Golden Omega Company Information Table 104. Golden Omega Business Overview Table 105. Golden Omega EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Golden Omega EPA & DHA Omega-3 Product Portfolio Table 107. Golden Omega Recent Developments Table 108. GC Rieber Company Information Table 109. GC Rieber Business Overview Table 110. GC Rieber EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. GC Rieber EPA & DHA Omega-3 Product Portfolio Table 112. GC Rieber Recent Developments Table 113. EPAX Company Information Table 114. EPAX Business Overview Table 115. EPAX EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. EPAX EPA & DHA Omega-3 Product Portfolio Table 117. EPAX Recent Developments Table 118. DSM Company Information Table 119. DSM Business Overview Table 120. DSM EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 121. DSM EPA & DHA Omega-3 Product Portfolio Table 122. DSM Recent Developments Table 123. Croda Company Information Table 124. Croda Business Overview Table 125. Croda EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 126. Croda EPA & DHA Omega-3 Product Portfolio Table 127. Croda Recent Developments Table 128. Bioprocess Algae Company Information Table 129. Bioprocess Algae Business Overview Table 130. Bioprocess Algae EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 131. Bioprocess Algae EPA & DHA Omega-3 Product Portfolio Table 132. Bioprocess Algae Recent Developments Table 133. BASF Company Information Table 134. BASF Business Overview Table 135. BASF EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 136. BASF EPA & DHA Omega-3 Product Portfolio Table 137. BASF Recent Developments Table 138. Auqi Company Information Table 139. Auqi Business Overview Table 140. Auqi EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 141. Auqi EPA & DHA Omega-3 Product Portfolio Table 142. Auqi Recent Developments Table 143. Anti-Cancer Company Information Table 144. Anti-Cancer Business Overview Table 145. Anti-Cancer EPA & DHA Omega-3 Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 146. Anti-Cancer EPA & DHA Omega-3 Product Portfolio Table 147. Anti-Cancer Recent Developments Table 148. Global EPA & DHA Omega-3 Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 149. Global EPA & DHA Omega-3 Sales by Region (2021-2026) & (K Tons) Table 150. Global EPA & DHA Omega-3 Sales Market Share by Region (2021-2026) Table 151. Global EPA & DHA Omega-3 Sales by Region (2027-2032) & (K Tons) Table 152. Global EPA & DHA Omega-3 Sales Market Share by Region (2027-2032) Table 153. Global EPA & DHA Omega-3 Revenue by Region (2021-2026) & (US$ Million) Table 154. Global EPA & DHA Omega-3 Revenue Market Share by Region (2021-2026) Table 155. Global EPA & DHA Omega-3 Revenue by Region (2027-2032) & (US$ Million) Table 156. Global EPA & DHA Omega-3 Revenue Market Share by Region (2027-2032) Table 157. North America EPA & DHA Omega-3 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. North America EPA & DHA Omega-3 Sales by Country (2021-2026) & (K Tons) Table 159. North America EPA & DHA Omega-3 Sales by Country (2027-2032) & (K Tons) Table 160. North America EPA & DHA Omega-3 Revenue by Country (2021-2026) & (US$ Million) Table 161. North America EPA & DHA Omega-3 Revenue by Country (2027-2032) & (US$ Million) Table 162. Europe EPA & DHA Omega-3 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. Europe EPA & DHA Omega-3 Sales by Country (2021-2026) & (K Tons) Table 164. Europe EPA & DHA Omega-3 Sales by Country (2027-2032) & (K Tons) Table 165. Europe EPA & DHA Omega-3 Revenue by Country (2021-2026) & (US$ Million) Table 166. Europe EPA & DHA Omega-3 Revenue by Country (2027-2032) & (US$ Million) Table 167. Asia Pacific EPA & DHA Omega-3 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 168. Asia Pacific EPA & DHA Omega-3 Sales by Country (2021-2026) & (K Tons) Table 169. Asia Pacific EPA & DHA Omega-3 Sales by Country (2027-2032) & (K Tons) Table 170. Asia Pacific EPA & DHA Omega-3 Revenue by Country (2021-2026) & (US$ Million) Table 171. Asia Pacific EPA & DHA Omega-3 Revenue by Country (2027-2032) & (US$ Million) Table 172. South America EPA & DHA Omega-3 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 173. South America EPA & DHA Omega-3 Sales by Country (2021-2026) & (K Tons) Table 174. South America EPA & DHA Omega-3 Sales by Country (2027-2032) & (K Tons) Table 175. South America EPA & DHA Omega-3 Revenue by Country (2021-2026) & (US$ Million) Table 176. South America EPA & DHA Omega-3 Revenue by Country (2027-2032) & (US$ Million) Table 177. Middle East and Africa EPA & DHA Omega-3 Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 178. Middle East and Africa EPA & DHA Omega-3 Sales by Country (2021-2026) & (K Tons) Table 179. Middle East and Africa EPA & DHA Omega-3 Sales by Country (2027-2032) & (K Tons) Table 180. Middle East and Africa EPA & DHA Omega-3 Revenue by Country (2021-2026) & (US$ Million) Table 181. Middle East and Africa EPA & DHA Omega-3 Revenue by Country (2027-2032) & (US$ Million) Table 182. Global EPA & DHA Omega-3 Sales by Type (2021-2026) & (K Tons) Table 183. Global EPA & DHA Omega-3 Sales by Type (2027-2032) & (K Tons) Table 184. Global EPA & DHA Omega-3 Sales Market Share by Type (2021-2026) Table 185. Global EPA & DHA Omega-3 Sales Market Share by Type (2027-2032) Table 186. Global EPA & DHA Omega-3 Revenue by Type (2021-2026) & (US$ Million) Table 187. Global EPA & DHA Omega-3 Revenue by Type (2027-2032) & (US$ Million) Table 188. Global EPA & DHA Omega-3 Revenue Market Share by Type (2021-2026) Table 189. Global EPA & DHA Omega-3 Revenue Market Share by Type (2027-2032) Table 190. Global EPA & DHA Omega-3 Price by Type (2021-2026) & (US$/Ton) Table 191. Global EPA & DHA Omega-3 Price by Type (2027-2032) & (US$/Ton) Table 192. Global EPA & DHA Omega-3 Sales by Application (2021-2026) & (K Tons) Table 193. Global EPA & DHA Omega-3 Sales by Application (2027-2032) & (K Tons) Table 194. Global EPA & DHA Omega-3 Sales Market Share by Application (2021-2026) Table 195. Global EPA & DHA Omega-3 Sales Market Share by Application (2027-2032) Table 196. Global EPA & DHA Omega-3 Revenue by Application (2021-2026) & (US$ Million) Table 197. Global EPA & DHA Omega-3 Revenue by Application (2027-2032) & (US$ Million) Table 198. Global EPA & DHA Omega-3 Revenue Market Share by Application (2021-2026) Table 199. Global EPA & DHA Omega-3 Revenue Market Share by Application (2027-2032) Table 200. Global EPA & DHA Omega-3 Price by Application (2021-2026) & (US$/Ton) Table 201. Global EPA & DHA Omega-3 Price by Application (2027-2032) & (US$/Ton) Table 202. Key Raw Materials Table 203. Raw Materials Key Suppliers Table 204. EPA & DHA Omega-3 Distributors List Table 205. EPA & DHA Omega-3 Customers List Table 206. EPA & DHA Omega-3 Industry Trends Table 207. EPA & DHA Omega-3 Industry Drivers Table 208. EPA & DHA Omega-3 Industry Restraints Table 209. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. EPA & DHA Omega-3 Product Image Figure 5. Global EPA & DHA Omega-3 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global EPA & DHA Omega-3 Market Size (2021-2032) & (US$ Million) Figure 7. Global EPA & DHA Omega-3 Sales (2021-2032) & (K Tons) Figure 8. Global EPA & DHA Omega-3 Average Price (US$/Ton) & (2021-2032) Figure 9. Marine Animals Source Omega-3 Product Image Figure 10. Marine Plant Source Omega-3 Product Image Figure 11. Pet Foods Product Image Figure 12. Fortified Food and Beverage Product Image Figure 13. Dietary Supplements Product Image Figure 14. Pharmaceuticals Product Image Figure 15. Infant Formula Product Image Figure 16. Others Product Image Figure 17. Global EPA & DHA Omega-3 Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of EPA & DHA Omega-3, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 EPA & DHA Omega-3 Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global EPA & DHA Omega-3 Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global EPA & DHA Omega-3 Sales by Region in 2025 Figure 23. Global EPA & DHA Omega-3 Revenue by Region in 2025 Figure 24. North America EPA & DHA Omega-3 Market Size by Country in 2025 Figure 25. North America EPA & DHA Omega-3 Sales Market Share by Country (2021-2032) Figure 26. North America EPA & DHA Omega-3 Revenue Market Share by Country (2021-2032) Figure 27. United States EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe EPA & DHA Omega-3 Market Size by Country in 2025 Figure 30. Europe EPA & DHA Omega-3 Sales Market Share by Country (2021-2032) Figure 31. Europe EPA & DHA Omega-3 Revenue Market Share by Country (2021-2032) Figure 32. Germany EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Asia Pacific EPA & DHA Omega-3 Market Size by Country in 2025 Figure 38. Asia Pacific EPA & DHA Omega-3 Sales Market Share by Country (2021-2032) Figure 39. Asia Pacific EPA & DHA Omega-3 Revenue Market Share by Country (2021-2032) Figure 40. China EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Japan EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. South Korea EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. India EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Australia EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. China Taiwan EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Southeast Asia EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South America EPA & DHA Omega-3 Market Size by Country in 2025 Figure 49. South America EPA & DHA Omega-3 Sales Market Share by Country (2021-2032) Figure 50. South America EPA & DHA Omega-3 Revenue Market Share by Country (2021-2032) Figure 51. Mexico EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Brazil EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Argentina EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Middle East and Africa EPA & DHA Omega-3 Market Size by Country in 2025 Figure 55. Middle East and Africa EPA & DHA Omega-3 Sales Market Share by Country (2021-2032) Figure 56. Middle East and Africa EPA & DHA Omega-3 Revenue Market Share by Country (2021-2032) Figure 57. Turkey EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Saudi Arabia EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. UAE EPA & DHA Omega-3 Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Global EPA & DHA Omega-3 Sales Market Share by Type (2021-2032) Figure 61. Global EPA & DHA Omega-3 Revenue Market Share by Type (2021-2032) Figure 62. Global EPA & DHA Omega-3 Price (US$/Ton) by Type (2021-2032) Figure 63. Global EPA & DHA Omega-3 Sales Market Share by Application (2021-2032) Figure 64. Global EPA & DHA Omega-3 Revenue Market Share by Application (2021-2032) Figure 65. Global EPA & DHA Omega-3 Price (US$/Ton) by Application (2021-2032) Figure 66. EPA & DHA Omega-3 Value Chain Figure 67. EPA & DHA Omega-3 Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. EPA & DHA Omega-3 Industry Opportunities and Challenges

Scope & coverage.

Types
  • Marine Animals Source Omega-3
  • Marine Plant Source Omega-3
Applications
  • Pet Foods
  • Fortified Food and Beverage
  • Dietary Supplements
  • Pharmaceuticals
  • Infant Formula
  • Others
Companies covered
  • Shandong Yuwang Pharmaceutical
  • Xinzhou
  • TASA
  • Solutex
  • Skuny
  • Sinomega
  • Polaris
  • Orkla Health
  • Omega Protein
  • OLVEA Fish Oils
  • Nippon Suisan Kaisha
  • Maruha Nichiro Foods
  • Marine Ingredients
  • LYSI
  • Kinomega
  • KD Pharma
  • Hofseth BioCare
  • Golden Omega
  • GC Rieber
  • EPAX
  • DSM
  • Croda
  • Bioprocess Algae
  • BASF
  • Auqi
  • Anti-Cancer

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global EPA & DHA Omega-3 Market Size (2021-2032)
  4. 2.2.2 Global EPA & DHA Omega-3 Sales (2021-2032)
  5. 2.2.3 Global EPA & DHA Omega-3 Market Average Price (2021-2032)
  6. 2.3 EPA & DHA Omega-3 by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Marine Animals Source Omega-3
  9. 2.3.3 Marine Plant Source Omega-3
  10. 2.4 EPA & DHA Omega-3 by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Pet Foods
  13. 2.4.3 Fortified Food and Beverage
  14. 2.4.4 Dietary Supplements
  15. 2.4.5 Pharmaceuticals
  16. 2.4.6 Infant Formula
  17. 2.4.7 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global EPA & DHA Omega-3 Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global EPA & DHA Omega-3 Sales (K Tons) of Manufacturers (2021-2026)
  3. 3.3 Global EPA & DHA Omega-3 Revenue of Manufacturers (2021-2026)
  4. 3.4 Global EPA & DHA Omega-3 Average Price by Manufacturers (2021-2026)
  5. 3.5 Global EPA & DHA Omega-3 Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of EPA & DHA Omega-3, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of EPA & DHA Omega-3, Product Type & Application
  8. 3.8 Global Manufacturers of EPA & DHA Omega-3, Established Date
  9. 3.9 Global EPA & DHA Omega-3 Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Shandong Yuwang Pharmaceutical
  2. 4.1.1 Shandong Yuwang Pharmaceutical Company Information
  3. 4.1.2 Shandong Yuwang Pharmaceutical Business Overview
  4. 4.1.3 Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Product Portfolio
  6. 4.1.5 Shandong Yuwang Pharmaceutical Recent Developments
  7. 4.2 Xinzhou
  8. 4.2.1 Xinzhou Company Information
  9. 4.2.2 Xinzhou Business Overview
  10. 4.2.3 Xinzhou EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Xinzhou EPA & DHA Omega-3 Product Portfolio
  12. 4.2.5 Xinzhou Recent Developments
  13. 4.3 TASA
  14. 4.3.1 TASA Company Information
  15. 4.3.2 TASA Business Overview
  16. 4.3.3 TASA EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 TASA EPA & DHA Omega-3 Product Portfolio
  18. 4.3.5 TASA Recent Developments
  19. 4.4 Solutex
  20. 4.4.1 Solutex Company Information
  21. 4.4.2 Solutex Business Overview
  22. 4.4.3 Solutex EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Solutex EPA & DHA Omega-3 Product Portfolio
  24. 4.4.5 Solutex Recent Developments
  25. 4.5 Skuny
  26. 4.5.1 Skuny Company Information
  27. 4.5.2 Skuny Business Overview
  28. 4.5.3 Skuny EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Skuny EPA & DHA Omega-3 Product Portfolio
  30. 4.5.5 Skuny Recent Developments
  31. 4.6 Sinomega
  32. 4.6.1 Sinomega Company Information
  33. 4.6.2 Sinomega Business Overview
  34. 4.6.3 Sinomega EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Sinomega EPA & DHA Omega-3 Product Portfolio
  36. 4.6.5 Sinomega Recent Developments
  37. 4.7 Polaris
  38. 4.7.1 Polaris Company Information
  39. 4.7.2 Polaris Business Overview
  40. 4.7.3 Polaris EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Polaris EPA & DHA Omega-3 Product Portfolio
  42. 4.7.5 Polaris Recent Developments
  43. 4.8 Orkla Health
  44. 4.8.1 Orkla Health Company Information
  45. 4.8.2 Orkla Health Business Overview
  46. 4.8.3 Orkla Health EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Orkla Health EPA & DHA Omega-3 Product Portfolio
  48. 4.8.5 Orkla Health Recent Developments
  49. 4.9 Omega Protein
  50. 4.9.1 Omega Protein Company Information
  51. 4.9.2 Omega Protein Business Overview
  52. 4.9.3 Omega Protein EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Omega Protein EPA & DHA Omega-3 Product Portfolio
  54. 4.9.5 Omega Protein Recent Developments
  55. 4.10 OLVEA Fish Oils
  56. 4.10.1 OLVEA Fish Oils Company Information
  57. 4.10.2 OLVEA Fish Oils Business Overview
  58. 4.10.3 OLVEA Fish Oils EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 OLVEA Fish Oils EPA & DHA Omega-3 Product Portfolio
  60. 4.10.5 OLVEA Fish Oils Recent Developments
  61. 4.11 Nippon Suisan Kaisha
  62. 4.11.1 Nippon Suisan Kaisha Company Information
  63. 4.11.2 Nippon Suisan Kaisha Business Overview
  64. 4.11.3 Nippon Suisan Kaisha EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Nippon Suisan Kaisha EPA & DHA Omega-3 Product Portfolio
  66. 4.11.5 Nippon Suisan Kaisha Recent Developments
  67. 4.12 Maruha Nichiro Foods
  68. 4.12.1 Maruha Nichiro Foods Company Information
  69. 4.12.2 Maruha Nichiro Foods Business Overview
  70. 4.12.3 Maruha Nichiro Foods EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Maruha Nichiro Foods EPA & DHA Omega-3 Product Portfolio
  72. 4.12.5 Maruha Nichiro Foods Recent Developments
  73. 4.13 Marine Ingredients
  74. 4.13.1 Marine Ingredients Company Information
  75. 4.13.2 Marine Ingredients Business Overview
  76. 4.13.3 Marine Ingredients EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Marine Ingredients EPA & DHA Omega-3 Product Portfolio
  78. 4.13.5 Marine Ingredients Recent Developments
  79. 4.14 LYSI
  80. 4.14.1 LYSI Company Information
  81. 4.14.2 LYSI Business Overview
  82. 4.14.3 LYSI EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 LYSI EPA & DHA Omega-3 Product Portfolio
  84. 4.14.5 LYSI Recent Developments
  85. 4.15 Kinomega
  86. 4.15.1 Kinomega Company Information
  87. 4.15.2 Kinomega Business Overview
  88. 4.15.3 Kinomega EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Kinomega EPA & DHA Omega-3 Product Portfolio
  90. 4.15.5 Kinomega Recent Developments
  91. 4.16 KD Pharma
  92. 4.16.1 KD Pharma Company Information
  93. 4.16.2 KD Pharma Business Overview
  94. 4.16.3 KD Pharma EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 KD Pharma EPA & DHA Omega-3 Product Portfolio
  96. 4.16.5 KD Pharma Recent Developments
  97. 4.17 Hofseth BioCare
  98. 4.17.1 Hofseth BioCare Company Information
  99. 4.17.2 Hofseth BioCare Business Overview
  100. 4.17.3 Hofseth BioCare EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Hofseth BioCare EPA & DHA Omega-3 Product Portfolio
  102. 4.17.5 Hofseth BioCare Recent Developments
  103. 4.18 Golden Omega
  104. 4.18.1 Golden Omega Company Information
  105. 4.18.2 Golden Omega Business Overview
  106. 4.18.3 Golden Omega EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Golden Omega EPA & DHA Omega-3 Product Portfolio
  108. 4.18.5 Golden Omega Recent Developments
  109. 4.19 GC Rieber
  110. 4.19.1 GC Rieber Company Information
  111. 4.19.2 GC Rieber Business Overview
  112. 4.19.3 GC Rieber EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 GC Rieber EPA & DHA Omega-3 Product Portfolio
  114. 4.19.5 GC Rieber Recent Developments
  115. 4.20 EPAX
  116. 4.20.1 EPAX Company Information
  117. 4.20.2 EPAX Business Overview
  118. 4.20.3 EPAX EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 EPAX EPA & DHA Omega-3 Product Portfolio
  120. 4.20.5 EPAX Recent Developments
  121. 4.21 DSM
  122. 4.21.1 DSM Company Information
  123. 4.21.2 DSM Business Overview
  124. 4.21.3 DSM EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 DSM EPA & DHA Omega-3 Product Portfolio
  126. 4.21.5 DSM Recent Developments
  127. 4.22 Croda
  128. 4.22.1 Croda Company Information
  129. 4.22.2 Croda Business Overview
  130. 4.22.3 Croda EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Croda EPA & DHA Omega-3 Product Portfolio
  132. 4.22.5 Croda Recent Developments
  133. 4.23 Bioprocess Algae
  134. 4.23.1 Bioprocess Algae Company Information
  135. 4.23.2 Bioprocess Algae Business Overview
  136. 4.23.3 Bioprocess Algae EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Bioprocess Algae EPA & DHA Omega-3 Product Portfolio
  138. 4.23.5 Bioprocess Algae Recent Developments
  139. 4.24 BASF
  140. 4.24.1 BASF Company Information
  141. 4.24.2 BASF Business Overview
  142. 4.24.3 BASF EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 BASF EPA & DHA Omega-3 Product Portfolio
  144. 4.24.5 BASF Recent Developments
  145. 4.25 Auqi
  146. 4.25.1 Auqi Company Information
  147. 4.25.2 Auqi Business Overview
  148. 4.25.3 Auqi EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  149. 4.25.4 Auqi EPA & DHA Omega-3 Product Portfolio
  150. 4.25.5 Auqi Recent Developments
  151. 4.26 Anti-Cancer
  152. 4.26.1 Anti-Cancer Company Information
  153. 4.26.2 Anti-Cancer Business Overview
  154. 4.26.3 Anti-Cancer EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2021-2026)
  155. 4.26.4 Anti-Cancer EPA & DHA Omega-3 Product Portfolio
  156. 4.26.5 Anti-Cancer Recent Developments
5 Global EPA & DHA Omega-3 Market Scenario by Region
  1. 5.1 Global EPA & DHA Omega-3 Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global EPA & DHA Omega-3 Sales by Region: 2021-2032
  3. 5.2.1 Global EPA & DHA Omega-3 Sales by Region: 2021-2026
  4. 5.2.2 Global EPA & DHA Omega-3 Sales by Region: 2027-2032
  5. 5.3 Global EPA & DHA Omega-3 Revenue by Region: 2021-2032
  6. 5.3.1 Global EPA & DHA Omega-3 Revenue by Region: 2021-2026
  7. 5.3.2 Global EPA & DHA Omega-3 Revenue by Region: 2027-2032
  8. 5.4 North America EPA & DHA Omega-3 Market Facts & Figures by Country
  9. 5.4.1 North America EPA & DHA Omega-3 Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America EPA & DHA Omega-3 Sales by Country (2021-2032)
  11. 5.4.3 North America EPA & DHA Omega-3 Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe EPA & DHA Omega-3 Market Facts & Figures by Country
  15. 5.5.1 Europe EPA & DHA Omega-3 Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe EPA & DHA Omega-3 Sales by Country (2021-2032)
  17. 5.5.3 Europe EPA & DHA Omega-3 Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific EPA & DHA Omega-3 Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific EPA & DHA Omega-3 Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific EPA & DHA Omega-3 Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific EPA & DHA Omega-3 Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America EPA & DHA Omega-3 Market Facts & Figures by Country
  35. 5.7.1 South America EPA & DHA Omega-3 Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America EPA & DHA Omega-3 Sales by Country (2021-2032)
  37. 5.7.3 South America EPA & DHA Omega-3 Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa EPA & DHA Omega-3 Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa EPA & DHA Omega-3 Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa EPA & DHA Omega-3 Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa EPA & DHA Omega-3 Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global EPA & DHA Omega-3 Sales by Type (2021-2032)
  2. 6.1.1 Global EPA & DHA Omega-3 Sales by Type (2021-2032) & (K Tons)
  3. 6.1.2 Global EPA & DHA Omega-3 Sales Market Share by Type (2021-2032)
  4. 6.2 Global EPA & DHA Omega-3 Revenue by Type (2021-2032)
  5. 6.2.1 Global EPA & DHA Omega-3 Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global EPA & DHA Omega-3 Revenue Market Share by Type (2021-2032)
  7. 6.3 Global EPA & DHA Omega-3 Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global EPA & DHA Omega-3 Sales by Application (2021-2032)
  2. 7.1.1 Global EPA & DHA Omega-3 Sales by Application (2021-2032) & (K Tons)
  3. 7.1.2 Global EPA & DHA Omega-3 Sales Market Share by Application (2021-2032)
  4. 7.2 Global EPA & DHA Omega-3 Revenue by Application (2021-2032)
  5. 7.2.1 Global EPA & DHA Omega-3 Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global EPA & DHA Omega-3 Revenue Market Share by Application (2021-2032)
  7. 7.3 Global EPA & DHA Omega-3 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 EPA & DHA Omega-3 Value Chain Analysis
  2. 8.1.1 EPA & DHA Omega-3 Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 EPA & DHA Omega-3 Production Mode & Process
  5. 8.2 EPA & DHA Omega-3 Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 EPA & DHA Omega-3 Distributors
  8. 8.2.3 EPA & DHA Omega-3 Customers
9 Global EPA & DHA Omega-3 Analyzing Market Dynamics
  1. 9.1 EPA & DHA Omega-3 Industry Trends
  2. 9.2 EPA & DHA Omega-3 Industry Drivers
  3. 9.3 EPA & DHA Omega-3 Industry Opportunities and Challenges
  4. 9.4 EPA & DHA Omega-3 Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst